Effects of left-ventricular assist using a co-axial flow pump (Hemopump) on organ blood flow during experimental cardiogenic shock

  • P. F. Wouters
Conference paper


The preservation of vital organ function appears to be a critical determinant of long-term outcome in patients treated with ventricular assist devices (VAD). Renal failure and multiple organ failure are among the most frequently reported fatal complications during and following temporary mechanical circulatory assist (MCA) (14, 13). Undoubtedly, reversibility of organ dysfunction is primarily determined by the duration of cardiogenic shock which preceeds the initiation of MCA (17). However, changes in regional blood flow distribution due to the use of MCA devices may play an important role as well. Changes in hormonal and neurotransmitter tone have been reported, and it has been clearly demonstrated that MCA alters blood rheology and fluid homeostasis (5, 19). The significance of pulse pressure, the minimum perfusion pressure, and amount of flow delivered by a VAD required to maintain adequate peripheral blood flow remain to be determined. In animals with normal cardiac function, regional blood flow distribution is well maintained with the use of VAD’s (6) The potential of the various types of MCA, however, to restore regional blood flow distribution following a period of critically disturbed and rapidly deteriorating regional blood flow is still controversial. Sukehiro et al. demonstrated that following a period of severe cardiogenic shock, renal blood flow could not be restored to pre-shock values with the use of a centrifugal, non-pulsatile flow VAD (18).


Cardiogenic Shock Left Ventricular Assist Device Bronchial Artery Ventricular Assist Device Left Anterior Descend Occlusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bush LR, Buja LM, Samowitz W, Rude RE, Wathen M, Tilton GD, Willerson JT ( 1983 Recovery of Left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs. Circ Res 53: 248–263PubMedCrossRefGoogle Scholar
  2. 2.
    Dennis C, Hall DP, Moreno JR, Senning A (1962) Reduction of the oxygen utilization of the heart by left heart bypass. Circ Research 10: 298–305CrossRefGoogle Scholar
  3. 3.
    Flameng W, Winkler B, Wuesten B, Schaper W (1977) Minimum requirements for the measurement of regional myocardial blood flow using tracer microspheres. Bibl Anat 15: 24–29PubMedGoogle Scholar
  4. 4.
    Greenway CV, Stark RD (1971) Hepatic vascular bed. Physiol Rev 51: 23–65PubMedGoogle Scholar
  5. 5.
    Hung T-C, Butter DB, Kormos RL, Sun Z, Borovetz HS, Griffith BP, Yie C-L (1989) Characteristics of blood rheology in patients during novacor left ventricular system support. ASAIO Transactions 35: 611–613PubMedCrossRefGoogle Scholar
  6. 6.
    Johnston GG, Hammill F, Marzec U (1976) Prolonged pulseless perfusion in unanaesthetized calves. Arch Surg 111: 1225–1230PubMedCrossRefGoogle Scholar
  7. 7.
    Keppel G (1982) Correction for multiple comparisons. Design and Analysis. Prentice-Hall 144–166Google Scholar
  8. 8.
    Kobayashi S, Takahashi H, Nishiyama H, et al (1982) Studies on left ventricular bypass: the preventive measure of excess negative pressure upon the inside of left atrium during left ventricular bypass. Jpn J Artif Organs 11: 131–134Google Scholar
  9. 9.
    Kresh JY, Kerkhof PLM, Goldman SM, Brockman SK (1986) Heart-Mechanical assist device interaction. ASAIO Trans 32: 437–443PubMedCrossRefGoogle Scholar
  10. 10.
    Lavallee M, Cox D, Patrick TA, Vatner SF (1983) Salvage of myocardial function by coronary artery reperfusion 1, 2, and 3 hours after occlusion in conscious dogs. Cire Res 53: 235–247Google Scholar
  11. 11.
    Mackoviack JA, Dasse KA, Poirier VL (1990) Mechanical cardiac assistance and replacement. Heart Transplantation 8: 39–53Google Scholar
  12. 12.
    Merhige ME, Smalling RW, Cassidy D, Barret R, Wise G, Short J, Wampler RK (1989) Effect of the Hemopump Left Ventricular Assist Device on Regional Myocardial Perfusion and Function. Circulation 80 (Suppl III): III158–III166Google Scholar
  13. 13.
    Parascandola SA, Pae WE, Davis PK, Miller CA, Pierce WS, Waldhausen JA (1988) Determinants of survival in patients with ventricular assist devices. ASAIO Transactions 34: 222–228PubMedGoogle Scholar
  14. 14.
    Pennington DG, Kanter KR, McBride LR, Kaiser GC, Barner HB, Miller LW, Naunheim KS, Fiore AC, Willman V (1988) Seven years’ experience with the Pierce-Donachy ventricular assist device. J Thorac Cardiovasc Surg 96: 901–911PubMedGoogle Scholar
  15. 15.
    Phang P T, Keough K M (1986) Inhibition of pulmonary Surfactant by plasma from normal adults and from patients having cardiopulmonary bypass. J Thorac Cardiovasc Surg 91: 248–251PubMedGoogle Scholar
  16. 16.
    Richardson PID, Withrington PG (1981) Liver blood flow. Gastroenterology 81: 159–173PubMedGoogle Scholar
  17. 17.
    Schoen FJ, Palmer DC, Bernhard WF, Pennington DG, Haudenschild CC, Ratliff NB, Berger RL, Golding LR, Watson JT (1986) Clinical temporary ventricular assist. Pathologic findings and their implications in a multi-institutional study of 41 patients. J Thorac Cardiovasc Surg 92: 1071–1081PubMedGoogle Scholar
  18. 18.
    Sukehiro S, Flameng W (1990) Effects of Left Ventricular Assist for cardiogenic shock on Cardiac function and Organ blood flow distribution. Ann Thorac Surg 50: 374–383PubMedCrossRefGoogle Scholar
  19. 19.
    Taenaka Y, Yagura A, Takano H, Matsuda T, Noda H, Kinoshita M, Takatani S, Akutsu T (1988) Altered humoral control of circulating volume during artificial circulation. ASAIO Transactions 34: 692–695PubMedGoogle Scholar
  20. 20.
    Vanhaecke J, Flameng W, Borgers M, Jang I, Van de Werf F, De Geest H (1990) Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circulation Research 67Google Scholar
  21. 21.
    Van de Werf F, Vanhaecke J, Jang I-K, Flameng W, Collen D, De Geest H (1987) Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with (3-adrenergic blockade with metoprolol. Circulation 75 (4): 830–836PubMedCrossRefGoogle Scholar
  22. 22.
    Wampler RK, Moise JC, Frazier OH, Olsen DB (1988) In vivo evaluation of a peripheral vascular access axial flow blood pump. ASAIO Transactions 34: 450–454PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • P. F. Wouters
    • 1
  1. 1.University Clinic GasthuisbergLeuvenBelgium

Personalised recommendations